What are the effects of Wegovy on your body?

The first few weeks: what most people actually experience

Imagine it's day three of your first Wegovy pen. You sit down to a meal you'd normally finish without thinking, and somewhere around the halfway point you feel genuinely full. That's the appetite signal doing its job. The 0.25 mg starting dose isn't there to produce weight loss immediately; it's low enough for your body to adjust before the dose climbs.

For many people, the effects of Wegovy in those opening weeks are dominated by the gut. Nausea is the most commonly reported effect, not violent, for most, but noticeable. Constipation, loose stools, burping and indigestion are also in the mix, and some people notice fatigue or mild headaches as their eating patterns change. The good news: these tend to settle within days to a couple of weeks at any given dose level. Eating smaller portions, avoiding very fatty foods and staying well hydrated all help your system adapt.

One practical check worth building into your routine: before each new pen, take a moment to confirm it's been stored correctly. Wegovy must be kept refrigerated at 2–8 °C until use. If a pen has been left out beyond the room-temperature window described in your Patient Information Leaflet, it should not be used. Thirty seconds of checking now avoids a wasted dose.

The full side-effect profile of Wegovy covers the complete list from the prescribing information, including less common effects worth knowing about.

What the clinical evidence shows about Wegovy's longer-term effects

The STEP 1 trial followed 1,961 adults with obesity or overweight for 68 weeks. On the 2.4 mg maintenance dose, participants lost around 15% of body weight on average, measured alongside a reduced-calorie diet and increased physical activity. That figure comes from the STEP 1 paper published in the New England Journal of Medicine, and it remains the benchmark quoted by NICE and the NHS.

Beyond weight, the effects of semaglutide extend to metabolic markers. Blood pressure, fasting glucose and lipid levels improved in trial participants, which is part of why semaglutide received a separate UK licence for reducing the risk of major cardiovascular events in eligible adults. These aren't effects that happen overnight, and they depend heavily on the lifestyle changes that accompany treatment, the medicine lowers the barrier; the habits do the rest.

Wegovy's effects on the brain are also increasingly studied. GLP-1 receptors exist in areas of the brain involved in reward and food-cue responses, which may explain why cravings for highly processed foods seem to diminish for some people on treatment. The research on Wegovy's neurological effects is still developing, but the early picture is interesting.

The higher 7.2 mg dose, approved by the MHRA in early 2026, showed around 20.7% average weight loss over 72 weeks in trials, narrowing the gap with tirzepatide. Whether that dose is suitable for you is a conversation for a prescriber, not a decision to make from a webpage.

Effects that catch people off-guard, and when to seek help

Most Wegovy effects are predictable and manageable. Some are not. Pancreatitis is a known but infrequent serious risk: the MHRA issued a Drug Safety Update for GLP-1 medicines in January 2026 specifically to ensure patients know the warning sign, severe, persistent stomach pain that extends into the back, with or without vomiting. That symptom needs same-day medical attention. Don't wait it out.

Gallbladder problems are also associated with rapid weight loss and GLP-1 medicines specifically; symptoms include upper-right abdominal pain, especially after eating. Dehydration from prolonged vomiting or diarrhoea can affect kidney function, and if you've been wondering whether Wegovy acts as a diuretic, that page explains how the medicine relates to fluid balance and why dehydration deserves attention. And anyone who notices unusual changes in mood or has thoughts of self-harm while on treatment should contact their prescriber or GP promptly.

Wegovy is not recommended during pregnancy, while breastfeeding, or if you're actively trying to conceive. It is not licensed for under-18s. If surgery is planned, tell your anaesthetist and surgical team that you're taking a GLP-1 medicine. These are the facts the NHS's semaglutide information page lays out clearly, and they're worth reading before you start.

You can report any suspected side effect directly to the MHRA via the Yellow Card scheme, it contributes to ongoing safety monitoring for all patients on these medicines.

Wegovy's effects on menstrual cycles are one of the questions our prescribers field regularly. If that's a concern for you, this page on Wegovy and periods covers what's known and what remains uncertain.

How eligibility, cost and clinical oversight shape what you actually experience

The effects of Wegovy only materialise if you can access it legally and safely, through a prescription following a proper assessment. On the NHS, semaglutide for weight management is available through specialist weight management services under NICE guidance (TA875), with waiting lists that vary widely by area. Private prescribing removes the waiting, but it does mean paying.

If cost is part of your calculation, current Wegovy pricing gives you an honest picture of what private treatment involves. The short version: legitimate private treatment includes a consultation, a prescription reviewed by a qualified clinician, and clinical support, not just a pen in a box. Price matters, but for a prescription medicine it's not the measure that determines whether you're safe.

At nume, consultations are assessed the same day by a GPhC-registered Independent Prescriber, a real clinician reading your answers, not software processing them. Before starting, some people also want to know whether Wegovy is a controlled substance, which is a reasonable question given the regulations that apply to some prescription medicines. Treatment, once approved, is dispatched for free next-working-day delivery. Every repeat order goes through a fresh clinical review. If you'd like to explore whether Wegovy is appropriate for you, start your free consultation and a prescriber will take it from there.